PharmaCyte Biotech, Inc. Stock Other OTC
Equities
PMCB
US71715X1046
Pharmaceuticals
Sales 2022 | - | Sales 2023 | - | Capitalization | 50.93M 69.51M |
---|---|---|---|---|---|
Net income 2022 | -4M -5.46M | Net income 2023 | -4M -5.46M | EV / Sales 2022 | - |
Net cash position 2022 | 85.4M 117M | Net cash position 2023 | 68.04M 92.86M | EV / Sales 2023 | - |
P/E ratio 2022 |
-8.53
x | P/E ratio 2023 |
-13.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 35.95% |
Managers | Title | Age | Since |
---|---|---|---|
Joshua Silverman
CEO | Chief Executive Officer | 53 | 22-08-14 |
Carlos Trujillo
DFI | Director of Finance/CFO | 66 | 14-12-31 |
José Iglesias
CTO | Chief Tech/Sci/R&D Officer | - | 20-08-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Weinstein
BRD | Director/Board Member | 64 | 22-11-13 |
Joshua Silverman
CEO | Chief Executive Officer | 53 | 22-08-14 |
Wayne Walker
BRD | Director/Board Member | 65 | 22-12-27 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |